Richard S. Creager, Phd

Seraph Biosciences, Inc. is a biomedical device company headquartered in Detroit, Michigan. The company was founded in 2014 with the primary purpose of commercializing its groundbreaking, diagnostic technology known as Seraspec®. Seraphs team consists of seasoned academic physicians, biomedical engineers, artificial intelligence experts, and device commercialization professionals tasked with combatting the major public health crises of our time. By leveraging the principles of Raman Spectroscopy, Seraspec® represents a paradigm shift away from current methods for screening and identification of dangerous bacterial, viral and fungal pathogens. Seraspecs® patented technology and method of detection effectively eliminates the need for time-consuming and costly laboratory-based methods of specimen collection, processing and pathogen identification. Safety, efficiency, accuracy and profitability are simultaneously enhanced through a portable, point-of-need technology for real-time pathogen detection and identification. A higher power just got involved in the fight against infection.

Ubiquitome seeks to connect the world to meaningful genomic information through handheld, cloud connected genetic analysis devices.

Based in the Genomics Capital of San Diego, ROSALIND is the first-ever genomics discovery and collaboration platform specifically designed for scientists and biologists. With ROSALIND, anyone can explore and interpret multi-omic datasets, without any prior bioinformatics skills. Named in honor of pioneering researcher Rosalind Franklin, who made a major contribution to the discovery of the double-helix structure of DNA with her famous photograph 51, the ROSALIND platform aims to simplify the practice of genomic data interpretation, so that biologists, researchers and drug developers can harness the potential of genomic information while reducing costs and increasing productivity. ROSALIND puts the Scientist (back) into the driver’s seat for the exploration and interpretation of datasets, radically reducing the time from sequencing to insight. Register for Free: https://app.rosalind.bio/login Learn more about Enterprise pricing and capabilities by contacting sales@rosalind.bio Follow us on Twitter (@Rosalind_Bio) and Facebook, or visit us at www.rosalind.bio

Experienced R&D, sales, marketing, business & distribution leaders who deliver unique value to diagnostics companies by developing and implementing market-driven strategies. Our target clients are small to medium sized companies or business units who are struggling to understand how to successfully bring great new products to attractive new markets. We fill knowledge and expertise gaps and provide market development and sales services to ensure successful implementation of winning strategies. This creates deep accountability for the work we do, and our client’s success is how we measure our own.

Seraph Biosciences, Inc. is a biomedical device company headquartered in Detroit, Michigan. The company was founded in 2014 with the primary purpose of commercializing its groundbreaking, diagnostic technology known as Seraspec®. Seraphs team consists of seasoned academic physicians, biomedical engineers, artificial intelligence experts, and device commercialization professionals tasked with combatting the major public health crises of our time. By leveraging the principles of Raman Spectroscopy, Seraspec® represents a paradigm shift away from current methods for screening and identification of dangerous bacterial, viral and fungal pathogens. Seraspecs® patented technology and method of detection effectively eliminates the need for time-consuming and costly laboratory-based methods of specimen collection, processing and pathogen identification. Safety, efficiency, accuracy and profitability are simultaneously enhanced through a portable, point-of-need technology for real-time pathogen detection and identification. A higher power just got involved in the fight against infection.

Ubiquitome seeks to connect the world to meaningful genomic information through handheld, cloud connected genetic analysis devices.

Based in the Genomics Capital of San Diego, ROSALIND is the first-ever genomics discovery and collaboration platform specifically designed for scientists and biologists. With ROSALIND, anyone can explore and interpret multi-omic datasets, without any prior bioinformatics skills. Named in honor of pioneering researcher Rosalind Franklin, who made a major contribution to the discovery of the double-helix structure of DNA with her famous photograph 51, the ROSALIND platform aims to simplify the practice of genomic data interpretation, so that biologists, researchers and drug developers can harness the potential of genomic information while reducing costs and increasing productivity. ROSALIND puts the Scientist (back) into the driver’s seat for the exploration and interpretation of datasets, radically reducing the time from sequencing to insight. Register for Free: https://app.rosalind.bio/login Learn more about Enterprise pricing and capabilities by contacting sales@rosalind.bio Follow us on Twitter (@Rosalind_Bio) and Facebook, or visit us at www.rosalind.bio

Founded as Tech Coast Angels in 1997, Tech Coast Angels Venture Group (TCA VG) has invested approximately $300 million in more than 525 companies, attracting an additional $2.2 billion in capital. With 400+ accredited investors in TCA LA, TCA OC, TCA Inland Empire, Pasadena Angels, and MEDA Angels, TCA VG is a key seed and early-stage funding source. Members, including founders and business leaders, deliver more than capital — providing counsel, mentorship, and access to extensive networks.